Physician profile
Howard K Schultz
NPI 1164450920
$3,583.14
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,774 · 2020: $1,087 · 2021: $722.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $420.79 | 2019-2021 | |
| Amgen INC. | $403.57 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $368.65 | 2019-2021 | |
| Pfizer INC. | $291.81 | 2019-2021 | |
| Novo Nordisk INC | $290.49 | 2019-2021 | |
| Amarin Pharma, INC. | $178.32 | 2019-2021 | |
| Lilly USA, LLC | $176.53 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.72 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $122.83 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $111.35 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.45 | 2019-2020 | |
| Allergan, INC. | $105.35 | 2019-2020 | |
| Glaxosmithkline, LLC. | $103.75 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $82.82 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $66.90 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $62.56 | 2020-2021 | |
| Abbvie INC. | $61.18 | 2021 | |
| Horizon Therapeutics Plc | $60.89 | 2019 | |
| Sanofi Pasteur INC. | $54.77 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.57 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $45.42 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $37.86 | 2019 | |
| Medtronic Vascular, INC. | $33.80 | 2019-2020 | |
| Shire North American Group INC | $33.60 | 2019 | |
| Jazz Pharmaceuticals INC. | $29.79 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $26.48 | 2019 | |
| Medicure Pharma INC. | $20.35 | 2021 | |
| Gilead Sciences, INC. | $18.42 | 2021 | |
| Esperion Therapeutics, INC. | $17.43 | 2021 | |
| Adlon Therapeutics L.P. | $15.41 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.22 | 2021 | |
| Ironshore Pharmaceuticals INC. | $14.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.